Fentanyl Transdermal Patch and Tazemetostat: Interaction Details
- Tazemetostat
- Tazverik
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Tazemetostat interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Tazemetostat
What can happen when they are taken together (rated Major)
Reduced exposure and reduced of CYP3A substrate
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving tazemetostat together with CYP3A substrates can lower the exposure to those substrates, which may weaken their efficacy. In a drug interaction study in patients, tazemetostat 800 mg twice daily was given with oral midazolam, a sensitive CYP3A substrate, and midazolam fell by 40% while fell by 21%.1
The Fentanyl Transdermal Patch and Tazemetostat Interaction, Explained
Tazverik (tazemetostat) can speed up how fast your body breaks down certain medicines, including fentanyl. Fentanyl is cleared mostly by an enzyme called . When that enzyme works faster, less fentanyl may stay in your blood, so your patch might not control your pain as well as expected.
This does not mean you should change anything on your own. Keep using your patch exactly as prescribed, and let your pharmacist or doctor know if your pain seems worse or comes back between patch changes. Your care team can adjust and individualize your plan and may check on you more closely.
Mechanism: Tazemetostat induces . Fentanyl is a (active parent drug, not a ), so should lower fentanyl exposure and analgesic effect.
- Magnitude: With a sensitive CYP3A substrate, tazemetostat 800 mg BID lowered oral midazolam by 40% and by 21%. No fentanyl-specific data are cited.
- Onset: Unspecified. Evidence: probable. Severity on file: major.
- Management: Monitor for reduced analgesia and withdrawal symptoms. Fentanyl dose may need to be adjusted and individualized. If tazemetostat is later stopped, reassess for increased fentanyl effect and as induction wanes.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Tazemetostat Interact
The likely mechanism
of -substrate by tazemetostat
How to Manage the Fentanyl Transdermal Patch and Tazemetostat Interaction
Your care team can manage this by tailoring your treatment and watching how you respond.
- Keep using your fentanyl patch and taking Tazverik as prescribed. Do not change or stop either on your own.
- Tell your pharmacist or prescriber that you take both medicines.
- Report pain that is poorly controlled or returns before your next patch change, or signs of withdrawal such as restlessness, sweating, or nausea.
- Your fentanyl dose may need to be adjusted and individualized, and your team may monitor you more closely.
- If Tazverik is stopped or changed, tell your team, since your fentanyl needs may change.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Tazemetostat need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: TAZVERIK oral tablets, tazemetostat oral tablets
In a drug interaction study in patients, giving tazemetostat 800 mg twice daily together with oral midazolam (a sensitive ) lowered the and of midazolam by 40% and 21%, respectively.1
Fentanyl Transdermal Patch and Tazemetostat: Common Questions
How serious is the Fentanyl Transdermal Patch and Tazemetostat interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Tazemetostat interaction managed?
Your care team can manage this by tailoring your treatment and watching how you respond. Keep using your fentanyl patch and taking Tazverik as prescribed. Do not change or stop either on your own. Tell your pharmacist or prescriber that you take both medicines. Report pain that is poorly controlled or returns before your next patch change, or signs of withdrawal such as restlessness, sweating, or… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl Transdermal Patch and Tazemetostat Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Tazemetostat together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: TAZVERIK(R) oral tablets, tazemetostat oral tablets. Epizyme Inc (per FDA), Cambridge, MA, 2024. DailyMed
Other Serious Interactions of Fentanyl Transdermal Patch and Tazemetostat
Also serious with Tazemetostat
Also serious with Fentanyl Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.